Connect with us

Medical Marijuana

Marijuana Retail Report

Published

on

How Emergency Regulations Have Put Nebraska’s Medical Cannabis Industry ‘In Limbo’



LB1235 was introduced by the Committee on General Affairs

Nebraska lawmakers have advanced medical cannabis-related legislation for the first time, moving a bill aimed at funding and basic operations of the state’s Medical Cannabis Commission to the next round of discussion.

LB1235 was introduced by the General Affairs Committee on behalf of the Nebraska Medical Cannabis Commission at the request of Governor Jim Peelen. In its original form, the bill was designed to help the commission get started, according to committee chairman Sen. Rick Holdcroft.

“It’s providing funding so they can hire staff and get paid, it’ll give them a registry so they can start registering patients and caregivers and medical staff to make referrals, it’ll set up a seed sales program that will track mostly from seed so we can make sure it cuts down on any black markets,” Holdcroft said.

But advocates said the bill initially drew significant opposition because of concerns it would weaken patient protections. Christa Eggers of Nebraskans for Medical Marijuana said that while 75 percent of the feedback was positive, 25 percent were negative and resulted in the removal of patient protections.

“It gives full authority to the medical cannabis commission, and while we would have hoped and would have liked to have a commission that follows the will of the people, that takes into account public comment and public feedback, we haven’t seen that,” Eggers said.

To read the rest of this article on NTV, Click here

Glass House

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The company previously announced plans to separate adult and medical use

After set script, another public cannabis operator separated its medical marijuana from adult marijuana in an attempt to go public on the New York Stock Exchange.

But California-based vertically integrated operator Glass House Brands said in documents filed Thursday that it plans to go further than listing on the NYSE. In particular, the company stated that it is preparing for export and interstate trade.

The company previously said in a press release on Wednesday that it had applied to list on the NYSE after “unbundling” its medical and adult businesses.

If successful, Glass House would become the second U.S. cannabis company to go public on a major U.S. exchange, following Florida-based multi-state marijuana operator Trulieve Cannabis Corp.

To read the rest of this article on MJ Biz Daily, Click here

Continue Reading

Federal

Anti-Rescheduling Parties Ask Court To Stay Schedule III Cannabis Order

Published

on

By

Anti-Rescheduling Parties Ask Court To Stay Schedule III Cannabis Order

A national organization that promotes drug-free workplaces and a pharmaceutical company that specializes in cannabinoids filed a petition in federal court on June 9 to try to stop the Trump administration’s immediate devolution of medical cannabis.

The National Drug and Alcohol Administration Association (NDASA) and MMJ International Holdings, whose subsidiary has an active DEA Schedule I analytical laboratory registration, asked the U.S. Court of Appeals for the District of Columbia Circuit on April 22 to stop U.S. Attorney General Todd Blanche from acting. signed an order reclassifying the state license for medical cannabis to Schedule III until the court case to set aside the entire order is decided.

The plaintiffs argue that the court must consider four factors:

  1. A lawsuit between the human rights group NORML and the Drug Enforcement Administration (DEA) nearly 50 years ago;
  2. The transfer order “illegally” bypassed regulatory notice and comment;
  3. Two plaintiffs will “suffer irreparable harm” without a stay; and
  4. The balance of equity and public interest.

To read the rest of this article on Cannabis Business Times, Click here

Post Parties opposing deadline ask court to delay Schedule III cannabis order first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading

alabama

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Sales under the state license began today

Patients who meet state requirements can finally access approved medical cannabis products from licensed dispensaries in Alabama.

Selling with a state license began today, more than five years after lawmakers adopted legislation regulation of the medical marijuana market. For years, the program’s rollout has been delayed by litigation — at one time with regulators suspension licensing process in general.

“For five long years, Alabama patients have not been able to locally obtain medically necessary, state-approved cannabis products from state-licensed dispensaries,” said NORML Deputy Director Paul Armentano. “These unwarranted delays have caused unnecessary suffering and needlessly put the health and well-being of patients at risk. Starting today, lawmakers, regulators and licensed providers must start putting patients’ needs first.”

To read the rest of this article on NORML, Click here

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media